AP NEWS

The 2018 Spinal Muscular Atrophy Market and Competitive Landscape in Europe - ResearchAndMarkets.com

December 7, 2018

DUBLIN--(BUSINESS WIRE)--Dec 7, 2018--The “Europe Spinal Muscular Atrophy Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

This latest research provides comprehensive insights into Spinal Muscular Atrophy pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Spinal Muscular Atrophy market size and drug sales. This research also provides insights into Spinal Muscular Atrophy epidemiology and late stage pipeline.

The research is classified into following sections - Spinal Muscular Atrophy overview with definitions, symptoms, etiology, diagnosis, treatment options; Spinal Muscular Atrophy pipeline insights covering late stage clinical trials pipeline; Spinal Muscular Atrophy prevalence trends by countries; Spinal Muscular Atrophy market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Benefits of this Research

Evaluate commercial market opportunities for Spinal Muscular Atrophy drugs Synthesize insights for business development & licensing Track market size, competitor drug sales, market shares in Spinal Muscular Atrophy market Develop in-depth knowledge of competition and markets Analyze sales data to update your brand planning trackers Develop tactics and strategies to take advantage of opportunities in the market Track market trends and analyze key events in Spinal Muscular Atrophy market Develop forecast models, healthcare frameworks, or economic models Answer key business questions; supports decision making in R&D to long term marketing strategies

Key Topics Covered

1. Spinal Muscular Atrophy: Disease Overview

2. Spinal Muscular Atrophy Pipeline Insights

3. Spinal Muscular Atrophy Epidemiology Analysis

4. Germany Spinal Muscular Atrophy Market Insights

5. France Spinal Muscular Atrophy Market Insights

6. Italy Spinal Muscular Atrophy Market Insights

7. Spain Spinal Muscular Atrophy Market Insights

8. UK Spinal Muscular Atrophy Market Insights

9. Europe Spinal Muscular Atrophy Market Insights

10. Research Methodology

For more information about this report, visit https://www.researchandmarkets.com/research/bjwg76/the_2018_spinal?w=4.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181207005225/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.comFor E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900Related Topics:Central Nervous System Drugs

KEYWORD: EUROPE

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/07/2018 09:00 AM/DISC: 12/07/2018 09:00 AM

http://www.businesswire.com/news/home/20181207005225/en

AP RADIO
Update hourly